OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel and potential future therapeutic options in systemic autoimmune diseases
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Lili Balogh, Katalin Oláh, Soma Sánta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Showing 10 citing articles:
The concept of difficult-to-treat disease in rheumatology: where next?
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access | Times Cited: 1
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access | Times Cited: 1
What's new on the horizon for rheumatoid arthritis management
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Extracellular vesicle as a next-generation drug delivery platform for rheumatoid arthritis therapy
Yi Jin, Cong Xu, Yujuan Zhu, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113610-113610
Closed Access
Yi Jin, Cong Xu, Yujuan Zhu, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113610-113610
Closed Access
Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
Ryan Soares, Jihad Ben Gabr, Mark M. Ash, et al.
Case Reports in Rheumatology (2025) Vol. 2025, Iss. 1
Open Access
Ryan Soares, Jihad Ben Gabr, Mark M. Ash, et al.
Case Reports in Rheumatology (2025) Vol. 2025, Iss. 1
Open Access
Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
Xian Lin, Jian Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Xian Lin, Jian Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Disrupting the immune homeostasis: the emerging role of macrophage ferroptosis in autoimmune diseases
Tian‐Fu Liu, Yichen Huang, Yizhe Wang, et al.
International Immunopharmacology (2025) Vol. 157, pp. 114745-114745
Closed Access
Tian‐Fu Liu, Yichen Huang, Yizhe Wang, et al.
International Immunopharmacology (2025) Vol. 157, pp. 114745-114745
Closed Access
The role of hypoxic microenvironment in autoimmune diseases
Xun Gong, S. Yang, Zhenyu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Xun Gong, S. Yang, Zhenyu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
Ananya Reddy Cingireddy, Brianna Flores, John Wuthrich, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ananya Reddy Cingireddy, Brianna Flores, John Wuthrich, et al.
Cureus (2024)
Open Access | Times Cited: 1
Targeted Therapy for Severe Sjogren’s Syndrome: A Focus on Mesenchymal Stem Cells
Carl Randall Harrell, Ana Volarevic, Aleksandar Arsenijević, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13712-13712
Open Access | Times Cited: 1
Carl Randall Harrell, Ana Volarevic, Aleksandar Arsenijević, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13712-13712
Open Access | Times Cited: 1
Az autoimmun gyulladás hátterében álló folyamatok megismerésének lehetőségei
Katalin Oláh, Tamás Németh
Orvosi Hetilap (2024) Vol. 165, Iss. 26, pp. 983-996
Closed Access
Katalin Oláh, Tamás Németh
Orvosi Hetilap (2024) Vol. 165, Iss. 26, pp. 983-996
Closed Access
